{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_18356", "batch_size": 260, "batch_pos": 209, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment uses neutral language like 'confirm we are in discussions', lacking high-potency verbs or metaphors.", "method": "llm_batch", "batch_id": "batch_2_17752", "batch_size": 260, "batch_pos": 188, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "The segment describes an action ('are in discussions'), not a moderate verb describing impact with scale.", "method": "llm_batch", "batch_id": "batch_3_15208", "batch_size": 260, "batch_pos": 174, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "No loaded rhetorical question is present.", "method": "llm_batch", "batch_id": "batch_4_14732", "batch_size": 260, "batch_pos": 172, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "Reports a fact but no explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_13684", "batch_size": 260, "batch_pos": 170, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_2152", "batch_size": 260, "batch_pos": 150, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_17876", "batch_size": 260, "batch_pos": 145, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 8, "answer": "yes", "rationale": "The segment describes development capability discussions: 'we are in discussions with the U.S. government on advancing our pandemic flu candidate'.", "method": "llm_batch", "batch_id": "batch_8_8824", "batch_size": 260, "batch_pos": 83, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
